Animal Microbiome Market
完整報告名稱與涵蓋範圍
Animal Microbiome Market Size, Share & Trends Analysis Report By Product (Phage Therapy Product, Functional Food, Sequencing Platforms, Feed Additives/Functional Ingredients, Alternative Proteins and Alternative Feed, Other), By Application, By Animal Type, By Region, And Segment Forecasts, 2025-2034
報告摘要
The worldwide Animal Microbiome Market stood at USD 7.2 Billion in 2024, and is set to reach USD 19.2 Billion by 2034, recording a CAGR of 10.6% from 2025 through 2034.
The Animal Microbiome sector involves referred to as the communities of microorganisms such as viruses, bacteria, and fungi that symbiotically live around, on, and in animals which contribute to animal well-being an. This domain has witnessed notable transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is driven by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in healthcare.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Animal Microbiome Market Snapshot
Chapter 4. Global Animal Microbiome Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Key Investments and Funding
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Technology Advancement in Animal Microbiome
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:
5.2.1. Phage Therapy Product
5.2.2. Functional Food
5.2.2.1. Probiotics
5.2.2.2. Prebiotics
5.2.2.3. Others
5.2.3. Sequencing Platforms
5.2.4. Feed Additives/Functional Ingredients
5.2.5. Alternative Proteins and Alternative Feed
5.2.6. Other Innovative Microbiome Products and Therapies
Chapter 6. Animal Microbiome Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application Analysis & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Disease Therapeutics
6.2.2. Diagnostics
6.2.3. Nutrition
Chapter 7. Animal Microbiome Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by product, 2021-2034
7.1.2. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by application, 2021-2034
7.1.3. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Animal Microbiome Market revenue (US$ Million) by product, 2021-2034
7.2.2. Europe Animal Microbiome Market revenue (US$ Million) by application, 2021-2034
7.2.3. Europe Animal Microbiome Market revenue (US$ Million) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Animal Microbiome Market revenue (US$ Million) by product, 2021-2034
7.3.2. Asia Pacific Animal Microbiome Market revenue (US$ Million) by application, 2021-2034
7.3.3. Asia Pacific Animal Microbiome Market revenue (US$ Million) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Animal Microbiome Market revenue (US$ Million) by product, (US$ Million)
7.4.2. Latin America Animal Microbiome Market revenue (US$ Million) by application, (US$ Million)
7.4.3. Latin America Animal Microbiome Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA revenue Animal Microbiome Market revenue (US$ Million) by product, (US$ Million) 2021-2034
7.5.2. MEA revenue Animal Microbiome Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.5.2.1. South Africa
7.5.2.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Adisseo France SAS
8.2.2. Animal Biome, Inc
8.2.3. ANIZOME LLC
8.2.4. Arm & Hammer Animal Nutrition
8.2.5. Cargill
8.2.6. Chr. Hansen Holding A/S
8.2.7. Cytophage Technologies Inc.
8.2.8. DuPont Industrial Biosciences
8.2.9. Elanco Animal Health
8.2.10. EnBiotix, Inc.
8.2.11. Gnubiotics Sciences SA
8.2.12. Hill's Pet Nutrition, Inc.
8.2.13. Intralytix
8.2.14. Jefo Nutrition Inc.
8.2.15. Koninklijke DSM N.V. (Royal DSM)
8.2.16. Lallemand Inc.
8.2.17. Land O'Lakes, Inc.
8.2.18. Leiber GmbH
8.2.19. MicroSintesis
8.2.20. Native Microbials
8.2.21. NomNomNow Inc.
8.2.22. Novozymes A/S
8.2.23. Novus International, Inc.
8.2.24. Ocean Harvest Technology
8.2.25. Orion Pharma Animal Health
8.2.26. Phage Technologies SA
8.2.27. Phagelux, Inc.
8.2.28. Phibro Animal Health Corporation
8.2.29. Phytobiotics Futterzusatzstoffe GmbH
8.2.30. Primal Health, LLC
8.2.31. ProDigest
8.2.32. Proteon Pharmaceuticals
8.2.33. Purina Animal Nutrition
8.2.34. Resilient Biotics
8.2.35. Tonisity International Limited
8.2.36. Vetanco
8.2.37. VetoPhage
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們